title: A systematic study on lyophilization process of polymersomes for long-term storage using doxorubicin-loaded (PEG)₃-PLA nanopolymersomes.
abstract: This study is focused on lyophilization process, physicochemical characterization and long-term storage stability studies of lyophilized doxorubicin-loaded (PEG)(3)-PLA nanopolymersomes. Nanopolymersomes were prepared by nanoprecipitation method using (PEG)(3)-PLA copolymer and lyophilized in the presence of different lyoprotectants and evaluated for physicochemical properties. The lyophilized product was studied for long-term stability at 2-8 °C, 25 °C/65% RH and 40 °C/75% RH over predetermined periods and evaluated for changes in physicochemical properties. In the absence of lyoprotectants, product was collapsed with no cake formation. In the presence of inulin, mannitol, gelatin, polyvinyl alcohol and glycine, nanopolymersome formulations demonstrated an intact cake occupying same volume as original frozen mass. The residual moisture content was below 2.5% w/w. The time of reconstitution was instantaneous following addition of water without any manual shaking. However, inulin found to be superior to the rest of lyoprotectants for overall lyophilizate physicochemical properties. Drug loaded nanopolymersome were physically stable and no effect was observed in terms of physicochemical properties following one year at 2-8 °C. In conclusion, the results suggest that doxorubicin loaded nanopolymersomes could be lyophilized using inulin 5% w/v without losing its physicochemical properties and can be stored at 2-8 °C with a provisional shelf life of more than a year.
authors.affiliation: Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research, SAS Nagar, Mohali 160062, Punjab, India.
authors.forename: Wubeante Yenet
authors.initials: WY
authors.lastname: Ayen
authors.forename: Neeraj
authors.initials: N
authors.lastname: Kumar
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000737:chemistry*; D011232:Chemical Precipitation; D002626:Chemistry, Pharmaceutical; D004317:Doxorubicin / Q000737:chemistry*; D004337:Drug Carriers; D004339:Drug Compounding; D004355:Drug Stability; D004356:Drug Storage; D005079:Excipients / Q000737:chemistry; D005612:Freeze Drying; D005780:Gelatin / Q000737:chemistry; D005998:Glycine / Q000737:chemistry; D006813:Humidity; D007444:Inulin / Q000737:chemistry; D008353:Mannitol / Q000737:chemistry; D053758:Nanoparticles; D036103:Nanotechnology; D011092:Polyethylene Glycols / Q000737:chemistry*; D011142:Polyvinyl Alcohol / Q000737:chemistry; D012995:Solubility; D013678:Technology, Pharmaceutical / Q000379:methods*; D013696:Temperature; D013997:Time Factors; D014867:Water / Q000737:chemistry
chemical_list: D000903:Antibiotics, Antineoplastic; D004337:Drug Carriers; D005079:Excipients; C542623:monomethoxypolyethyleneglycol-polylactide block copolymer; D014867:Water; D008353:Mannitol; D011092:Polyethylene Glycols; D004317:Doxorubicin; D005780:Gelatin; D011142:Polyvinyl Alcohol; D007444:Inulin; D005998:Glycine